The suppression of bcl-2 and IL-6 by either pre- and post-application of inhibitor is especially important because of bcl-2 role in anti-apoptosis [22] and IL-6 role as a cancer-related cytokine [23]. The gene discussed is BCL2; the disease is cancer.